Abstract

Human intestinal organoids (HIOs) are a promising in vitro model consisting of different intestinal cell types with a 3D microarchitecture resembling native tissue. In the current study, we aimed to assess the expression of the most common intestinal CYP enzymes in a human induced pluripotent stem cell (hiPSC)-derived HIO model, and the suitability of that model to study chemical-induced changes in CYP expression and activity. We compared this model with the commonly used human colonic adenocarcinoma cell line Caco-2 and with a human primary intestinal epithelial cell (IEC)-based model, closely resembling in vivo tissue. We optimized an existing protocol to differentiate hiPSCs into HIOs and demonstrated that obtained HIOs contain a polarized epithelium with tight junctions consisting of enterocytes, goblet cells, enteroendocrine cells and Paneth cells. We extensively characterized the gene expression of CYPs and activity of CYP3A4/5, indicating relatively high gene expression levels of the most important intestinal CYP enzymes in HIOs compared to the other models. Furthermore, we showed that CYP1A1 and CYP1B1 were induced by β-naphtoflavone in all three models, whereas CYP3A4 was induced by phenobarbital and rifampicin in HIOs, in the IEC-based model (although not statistically significant), but not in Caco-2 cells. Interestingly, CYP2B6 expression was not induced in any of the models by the well-known liver CYP2B6 inducer phenobarbital. In conclusion, our study indicates that hiPSC-based HIOs are a useful in vitro intestinal model to study biotransformation of chemicals in the intestine.

Highlights

  • Cytochrome P450 (CYP) enzymes play crucial roles in detoxification or bioactivation of chemicals

  • In the current study we aimed to assess the suitability of human induced pluripotent stem cell (hiPSC)-derived Human intestinal organoids (HIOs) as a model to study chemical-induced changes in CYP-expression and CYP activity, by characterizing the gene expression of the most common intestinal CYP enzymes and their inducibility in hiPSC-derived HIOs, as well as gene expression of some common intestinal enzymes involved in phase II metabolism

  • The differentiation procedure was characterized by gene expression measurements and immunohistochemical evaluation. hiPSCs were first differentiated into definitive endoderm (DE) using the nodalmimetic Activin A and BMP4

Read more

Summary

Introduction

Cytochrome P450 (CYP) enzymes play crucial roles in detoxification or bioactivation of chemicals. CYP expression and function is dependent on various factors, such as genetic polymorphisms, physiological factors (e.g., age, gender and (related) hormone levels) and pathological conditions (e.g., tumours and inflammation), which may impact chemical metabolism capacity (Cotreau et al 2005; Zanger and Schwab 2013; Stavropoulou et al 2018). Besides these factors, CYP functionality may be affected by chemicals, e.g., by increasing their expression levels and/or inhibiting their activity, which may result in unanticipated adverse reactions and lower therapeutic efficacy of drugs (Lynch and Price 2007; Hansten 2018)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call